BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
Open | $2.570 |
Close | - |
Volume / Avg. | 9.450K / 1.509M |
Day Range | 2.570 - 2.580 |
52 Wk Range | 1.910 - 29.560 |
Market Cap | $78.735M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 28.21% |
Days to Cover | 4.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by HC Wainwright & Co. on Tuesday, April 23, 2024. The analyst firm set a price target for 10.00 expecting BTAI to rise to within 12 months (a possible 288.35% upside). 27 analyst firms have reported ratings in the last year.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $2.575 last updated Today at April 30, 2024 at 9:36 AM EDT.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.